Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 160

1.

Identification of Epigenetic Methylation Signatures With Clinical Value in Crohn's Disease.

Moret-Tatay I, Cerrillo E, Sáez-González E, Hervás D, Iborra M, Sandoval J, Busó E, Tortosa L, Nos P, Beltrán B.

Clin Transl Gastroenterol. 2019 Oct 28. doi: 10.14309/ctg.0000000000000083. [Epub ahead of print]

PMID:
31703025
2.

[Duodenal type folicular lymphoma: case report and literature review].

Castro D, Beltrán B, Quiñones MDP, Palomino E, Cotrina E, Alva E, Bryan Medina J, Yábar A.

Rev Gastroenterol Peru. 2019 Jul-Sep;39(3):276-279. Spanish.

PMID:
31688853
3.

Identification of Epigenetic Methylation Signatures With Clinical Value in Crohn's Disease.

Moret-Tatay I, Cerrillo E, Sáez-González E, Hervás D, Iborra M, Sandoval J, Busó E, Tortosa L, Nos P, Beltrán B.

Clin Transl Gastroenterol. 2019 Oct;10(10):e00083. doi: 10.14309/ctg.0000000000000083.

PMID:
31663908
4.

Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on pouchitis in ulcerative colitis. Part 1: Epidemiology, diagnosis and prognosis.

Barreiro-de Acosta M, Gutierrez A, Rodríguez-Lago I, Espín E, Ferrer Bradley I, Marín-Jimenez I, Beltrán B, Chaparro M, Gisbert JP, Nos P; en representación de GETECCU.

Gastroenterol Hepatol. 2019 Nov;42(9):568-578. doi: 10.1016/j.gastrohep.2019.08.001. Epub 2019 Oct 9. English, Spanish.

5.

Functional rare variants influence the clinical response to anti-TNF therapy in Crohn's disease.

Chaparro M, Aterido A, Guerra I, Iborra M, Cabriada JL, Bujanda L, Taxonera C, García-Sánchez V, Marín-Jiménez I, Barreiro-de Acosta M, Vera I, Martín-Arranz MD, Hernández-Breijo B, Mesonero F, Sempere L, Gomollón F, Hinojosa J, Bermejo F, Beltrán B, Rodríguez-Pescador A, Banales JM, Olivares D, Aguilar-Melero P, Menchén L, Ferreiro-Iglesias R, Blazquez Gómez I, Benitez García B, Guijarro LG, Marin AC, Bernardo D, Marsal S, Julia A, Gisbert JP.

Therap Adv Gastroenterol. 2019 Sep 25;12:1756284819867848. doi: 10.1177/1756284819867848. eCollection 2019.

6.

Use of magnetic resonance index of activity (MaRIA) in the preoperative assessment of small bowel Crohn's disease.

Pous-Serrano S, Frasson M, Pàmies-Guilabert J, Rudenko P, Puchades-Román I, Beltrán B, Nos Mateu P, García-Granero E.

Cir Esp. 2019 Oct 2. pii: S0009-739X(19)30233-7. doi: 10.1016/j.ciresp.2019.06.018. [Epub ahead of print] English, Spanish.

PMID:
31585676
7.

Long-Distance Cooperative and Antagonistic RNA Polymerase Dynamics via DNA Supercoiling.

Kim S, Beltran B, Irnov I, Jacobs-Wagner C.

Cell. 2019 Sep 19;179(1):106-119.e16. doi: 10.1016/j.cell.2019.08.033.

PMID:
31539491
8.

Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients With Inflammatory Bowel Disease: Results From the Eneida Registry.

Casanova MJ, Chaparro M, Mínguez M, Ricart E, Taxonera C, García-López S, Guardiola J, López-San Román A, Iglesias E, Beltrán B, Sicilia B, Vera MI, Hinojosa J, Riestra S, Domènech E, Calvet X, Pérez-Calle JL, Martín-Arranz MD, Aldeguer X, Rivero M, Monfort D, Barrio J, Esteve M, Márquez L, Lorente R, García-Planella E, de Castro L, Bermejo F, Merino O, Rodríguez-Pérez A, Martínez-Montiel P, Van Domselaar M, Alcaín G, Domínguez-Cajal M, Muñoz C, Gomollón F, Fernández-Salazar L, García-Sepulcre MF, Rodríguez-Lago I, Gutiérrez A, Argüelles-Arias F, Rodriguez C, Rodríguez GE, Bujanda L, Llaó J, Varela P, Ramos L, Huguet JM, Almela P, Romero P, Navarro-Llavat M, Abad Á, Ramírez-de la Piscina P, Lucendo AJ, Sesé E, Madrigal RE, Charro M, García-Herola A, Pajares R, Khorrami S, Gisbert JP.

Inflamm Bowel Dis. 2019 Aug 29. pii: izz192. doi: 10.1093/ibd/izz192. [Epub ahead of print]

PMID:
31504569
9.

Editorial: real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease-results from the ENEIDA registry. Authors' reply.

Iborra M, Beltrán B, Nos P.

Aliment Pharmacol Ther. 2019 Sep;50(5):600-601. doi: 10.1111/apt.15447. No abstract available.

PMID:
31414541
10.

High Red Cell Distribution Width is an Adverse Predictive and Prognostic Factor in Patients With Diffuse Large B-Cell Lymphoma Treated With Chemoimmunotherapy.

Beltran BE, Paredes S, Castro D, Cotrina E, Sotomayor EM, Castillo JJ.

Clin Lymphoma Myeloma Leuk. 2019 Sep;19(9):e551-e557. doi: 10.1016/j.clml.2019.06.005. Epub 2019 Jun 15.

PMID:
31320254
11.

Development and Validation of a New Method for Determination of Pb and Cr in Marine Organisms by Total Reflection X-Ray Fluorescence (TXRF) Spectroscopy.

Beltrán BG, Martínez-Serrano I, Ramos-Sanchez V, Chávez-Flores D, Nevárez-Rodríguez MC, Suárez-Domínguez EA.

J Anal Methods Chem. 2019 May 27;2019:8150678. doi: 10.1155/2019/8150678. eCollection 2019.

12.

Real-world short-term effectiveness of ustekinumab in 305 patients with Crohn's disease: results from the ENEIDA registry.

Iborra M, Beltrán B, Fernández-Clotet A, Gutiérrez A, Antolín B, Huguet JM, De Francisco R, Merino O, Carpio D, García-López S, Mesonero F, Navarro P, Ferreiro-Iglesias R, Carbajo AY, Rivero M, Gisbert JP, Piñero-Pérez MC, Monfort D, Bujanda L, García-Sepulcre MF, Martín-Cardona A, Cañete F, Taxonera C, Domènech E, Nos P; GETECCU Group (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa).

Aliment Pharmacol Ther. 2019 Aug;50(3):278-288. doi: 10.1111/apt.15371. Epub 2019 Jun 20.

PMID:
31222872
13.

Bases for the Adequate Development of Nutritional Recommendations for Patients with Inflammatory Bowel Disease.

Sáez-González E, Mateos B, López-Muñoz P, Iborra M, Moret I, Nos P, Beltrán B.

Nutrients. 2019 May 12;11(5). pii: E1062. doi: 10.3390/nu11051062.

14.

Influence of Vitamin D Deficiency on Inflammatory Markers and Clinical Disease Activity in IBD Patients.

López-Muñoz P, Beltrán B, Sáez-González E, Alba A, Nos P, Iborra M.

Nutrients. 2019 May 11;11(5). pii: E1059. doi: 10.3390/nu11051059.

15.

Clinical characteristics, associated malignancies and management of primary sclerosing cholangitis in inflammatory bowel disease patients: A multicenter retrospective cohort study.

Guerra I, Bujanda L, Castro J, Merino O, Tosca J, Camps B, Gutiérrez A, Gordillo Ábalos J, de Castro L, Iborra M, Carbajo AY, Taxonera C, Rodríguez-Lago I, Mesonero F, de Francisco R, Gómez-Gómez GJ, Chaparro M, Tardillo CA, Rivero M, Algaba A, Martín Arranz E, Cañete F, Vicente R, Sicilia B, Antolín B, Prieto V, Márquez L, Benítez JM, Camo P, Piqueras M, Gargallo CJ, Hinojosa E, Huguet JM, Pérez Calle JL, Van Domselaar M, Rodriguez C, Calvet X, Muñoz-Villafranca C, García-Sepulcre MF, Munoz-Garrido P, Fernández-Clotet A, Gómez Irwin L, Hernández S, Guardiola J, Sempere L, González Muñoza C, Hernández V, Beltrán B, Barrio J, Alba C, Moraleja I, López-Sanromán A, Riestra S, Martínez Montiel P, Garre A, Arranz L, García MJ, Martín Arranz MD, Corsino P, Arias L, Fernández-Salazar L, Fernández-Pordomingo A, Andreu M, Iglesias E, Ber Y, Mena R, Arroyo Villarino MT, Mora M, Ruiz L, López-Serrano P, Blazquez I, Villoria A, Fernández M, Bermejo F, Banales JM, Domènech E, Gisbert JP; Spanish GETECCU group (ENEIDA Project).

J Crohns Colitis. 2019 May 7. pii: jjz094. doi: 10.1093/ecco-jcc/jjz094. [Epub ahead of print]

PMID:
31063540
16.

Idiopathic Retinal Vasculitis, Aneurysms, and Neuroretinitis Syndrome.

Weng CY, Esquenazi I, Beltran B.

Ophthalmol Retina. 2018 Sep;2(9):948. doi: 10.1016/j.oret.2018.06.006. Epub 2018 Sep 4. No abstract available.

PMID:
31047229
17.

Granulocyte-monocyte apheresis: an alternative combination therapy after loss of response to anti-TNF agents in ulcerative colitis.

Rodríguez-Lago I, Sempere L, Gutiérrez A, Núñez A, Leo Carnerero E, Hinojosa E, Mora M, Cañete F, Mañosa M, Herrera C, Beltrán B, Forés A, Arjona D, Barreiro-de Acosta M, Khorrami S, Aguirre U, Ginard D, Cabriada JL.

Scand J Gastroenterol. 2019 Apr;54(4):459-464. doi: 10.1080/00365521.2019.1600715. Epub 2019 Apr 14.

PMID:
30982369
18.

A Nomogram Combining Fecal Calprotectin Levels and Plasma Cytokine Profiles for Individual Prediction of Postoperative Crohn's Disease Recurrence.

Cerrillo E, Moret I, Iborra M, Pamies J, Hervás D, Tortosa L, Sáez-González E, Nos P, Beltrán B.

Inflamm Bowel Dis. 2019 Mar 29. pii: izz053. doi: 10.1093/ibd/izz053. [Epub ahead of print]

PMID:
30925193
19.

A fluorogenic array for temporally unlimited single-molecule tracking.

Ghosh RP, Franklin JM, Draper WE, Shi Q, Beltran B, Spakowitz AJ, Liphardt JT.

Nat Chem Biol. 2019 Apr;15(4):401-409. doi: 10.1038/s41589-019-0241-6. Epub 2019 Mar 11.

PMID:
30858596
20.

Choroidal Rupture Through the Fovea With Overlying Traumatic Epiretinal Membrane.

Weng CY, Beltran B.

JAMA Ophthalmol. 2019 Feb 1;137(2):e183971. doi: 10.1001/jamaophthalmol.2018.3971. Epub 2019 Feb 14. No abstract available.

PMID:
30763418
21.

Relevant Infections in Inflammatory Bowel Disease, and Their Relationship With Immunosuppressive Therapy and Their Effects on Disease Mortality.

Zabana Y, Rodríguez L, Lobatón T, Gordillo J, Montserrat A, Mena R, Beltrán B, Dotti M, Benitez O, Guardiola J, Domènech E, Garcia-Planella E, Calvet X, Piqueras M, Aceituno M, Fernández-Bañares F, Esteve M.

J Crohns Colitis. 2019 Jul 25;13(7):828-837. doi: 10.1093/ecco-jcc/jjz013.

PMID:
30668662
22.

Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse.

Iborra M, Herreras J, Boscá-Watts MM, Cortés X, Trejo G, Cerrillo E, Hervás D, Mínguez M, Beltrán B, Nos P.

Dig Dis Sci. 2019 Jun;64(6):1612-1621. doi: 10.1007/s10620-018-5429-1. Epub 2019 Jan 2.

PMID:
30604371
23.

Mogamulizumab versus investigator's choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma.

Phillips AA, Fields PA, Hermine O, Ramos JC, Beltran BE, Pereira J, Wandroo F, Feldman T, Taylor GP, Sawas A, Humphrey J, Kurman M, Moriya J, Dwyer K, Leoni M, Conlon K, Cook L, Gonsky J, Horwitz SM; 0761-009 Study Group.

Haematologica. 2019 May;104(5):993-1003. doi: 10.3324/haematol.2018.205096. Epub 2018 Dec 20.

24.

Bottom-up modeling of chromatin segregation due to epigenetic modifications.

MacPherson Q, Beltran B, Spakowitz AJ.

Proc Natl Acad Sci U S A. 2018 Dec 11;115(50):12739-12744. doi: 10.1073/pnas.1812268115. Epub 2018 Nov 26.

25.

Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients.

Chaparro M, Barreiro-de Acosta M, Echarri A, Almendros R, Barrio J, Llao J, Gomollón F, Vera M, Cabriada JL, Guardiola J, Guerra I, Beltrán B, Roncero O, Busquets D, Taxonera C, Calvet X, Ferreiro-Iglesias R, Ollero Pena V, Bernardo D, Donday MG, Garre A, Godino A, Díaz A, Gisbert JP.

Dig Dis Sci. 2019 Mar;64(3):846-854. doi: 10.1007/s10620-018-5362-3. Epub 2018 Nov 13.

PMID:
30426297
26.

Secondary Haemophagocytic Syndrome and Overlapping Immune Reconstitution Syndrome: Life-Threatening Complications of Anti-TNF-α Treatment for Crohn's Disease.

Sáez-González E, Salavert M, Cerrillo E, Moret I, Iborra M, Nos P, Beltrán B.

Am J Gastroenterol. 2019 Jan;114(1):177-179. doi: 10.1038/s41395-018-0420-1. No abstract available.

PMID:
30413818
27.

Heterozygous STUB1 mutation causes familial ataxia with cognitive affective syndrome (SCA48).

Genis D, Ortega-Cubero S, San Nicolás H, Corral J, Gardenyes J, de Jorge L, López E, Campos B, Lorenzo E, Tonda R, Beltran S, Negre M, Obón M, Beltran B, Fàbregas L, Alemany B, Márquez F, Ramió-Torrentà L, Gich J, Volpini V, Pastor P.

Neurology. 2018 Nov 20;91(21):e1988-e1998. doi: 10.1212/WNL.0000000000006550. Epub 2018 Oct 31.

PMID:
30381368
28.

Different Genetic Expression Profiles of Oxidative Stress and Apoptosis-Related Genes in Crohn's Disease.

Iborra M, Moret I, Rausell F, Busó E, Cerrillo E, Sáez-González E, Nos P, Beltrán B.

Digestion. 2019;100(1):27-36. doi: 10.1159/000493726. Epub 2018 Oct 9.

PMID:
30300886
29.

First Results from the DEAP-3600 Dark Matter Search with Argon at SNOLAB.

Amaudruz PA, Baldwin M, Batygov M, Beltran B, Bina CE, Bishop D, Bonatt J, Boorman G, Boulay MG, Broerman B, Bromwich T, Bueno JF, Burghardt PM, Butcher A, Cai B, Chan S, Chen M, Chouinard R, Cleveland BT, Cranshaw D, Dering K, DiGioseffo J, Dittmeier S, Duncan FA, Dunford M, Erlandson A, Fatemighomi N, Florian S, Flower A, Ford RJ, Gagnon R, Giampa P, Golovko VV, Gorel P, Gornea R, Grace E, Graham K, Gulyev E, Hakobyan R, Hall A, Hallin AL, Hamstra M, Harvey PJ, Hearns C, Jillings CJ, Kamaev O, Kemp A, Kuźniak M, Langrock S, La Zia F, Lehnert B, Lidgard JJ, Lim C, Lindner T, Linn Y, Liu S, Majewski P, Mathew R, McDonald AB, McElroy T, McGinn T, McLaughlin JB, Mead S, Mehdiyev R, Mielnichuk C, Monroe J, Muir A, Nadeau P, Nantais C, Ng C, Noble AJ, O'Dwyer E, Ohlmann C, Olchanski K, Olsen KS, Ouellet C, Pasuthip P, Peeters SJM, Pollmann TR, Rand ET, Rau W, Rethmeier C, Retière F, Seeburn N, Shaw B, Singhrao K, Skensved P, Smith B, Smith NJT, Sonley T, Soukup J, Stainforth R, Stone C, Strickland V, Sur B, Tang J, Taylor J, Veloce L, Vázquez-Jáuregui E, Walding J, Ward M, Westerdale S, Woolsey E, Zielinski J; DEAP-3600 Collaboration.

Phys Rev Lett. 2018 Aug 17;121(7):071801. doi: 10.1103/PhysRevLett.121.071801.

PMID:
30169081
30.

Fecal Calprotectin Pretreatment and Induction Infliximab Levels for Prediction of Primary Nonresponse to Infliximab Therapy in Crohn's Disease.

Beltrán B, Iborra M, Sáez-González E, Marqués-Miñana MR, Moret I, Cerrillo E, Tortosa L, Bastida G, Hinojosa J, Poveda-Andrés JL, Nos P.

Dig Dis. 2019;37(2):108-115. doi: 10.1159/000492626. Epub 2018 Aug 27.

PMID:
30149385
31.

En Bloc Resection of a Retinal Capillary Hemangioblastoma in a Young Female.

Weng CY, Shetlar DJ, Beltran B.

Ophthalmology. 2018 Aug;125(8):1188. doi: 10.1016/j.ophtha.2018.06.021. Epub 2018 Jul 4. No abstract available.

PMID:
30037395
32.

Vedolizumab, an option in patients with inflammatory bowel disease intolerant to thiopurines and refractory to biological agents.

Iborra M, Beltrán B, Maroto N, Navarro-Cortés P, Boscá-Watts M, Ferrer-Bradley I, García-Morales N, Sáez-González E, Hinojosa J, Mínguez M, Nos P.

Gastroenterol Hepatol. 2018 Nov;41(9):535-543. doi: 10.1016/j.gastrohep.2018.06.001. Epub 2018 Jul 19. English, Spanish.

PMID:
30031573
33.

EBV-positive diffuse large B-cell lymphoma, not otherwise specified: 2018 update on diagnosis, risk-stratification and management.

Castillo JJ, Beltran BE, Miranda RN, Young KH, Chavez JC, Sotomayor EM.

Am J Hematol. 2018 Jul;93(7):953-962. doi: 10.1002/ajh.25112. Review.

34.

The neutrophil-lymphocyte ratio is prognostic in patients with early stage aggressive peripheral T cell lymphoma.

Beltran BE, Castro D, De La Cruz-Vargas JA, Cotrina E, Gallo A, Sotomayor EM, Castillo JJ.

Br J Haematol. 2019 Feb;184(4):650-653. doi: 10.1111/bjh.15141. Epub 2018 Feb 26. No abstract available.

PMID:
29479670
35.

The impact of the neutrophil:lymphocyte ratio in response and survival of patients with de novo diffuse large B-cell lymphoma.

Beltrán BE, Paredes S, Cotrina E, Sotomayor EM, Castillo JJ.

Leuk Res. 2018 Apr;67:82-85. doi: 10.1016/j.leukres.2018.02.011. Epub 2018 Feb 19.

PMID:
29477024
36.

Combination therapy with cytapheresis plus vedolizumab in a corticosteroid-dependent patient with ulcerative colitis and previous ANTI-TNF-α drug failure.

Sáez-González E, Aguas M, Huguet JM, Nos P, Beltrán B.

Dig Liver Dis. 2018 Apr;50(4):415-417. doi: 10.1016/j.dld.2018.01.124. Epub 2018 Feb 1. No abstract available.

PMID:
29397323
37.

Alpha-defensins (α-Defs) in Crohn's disease: decrease of ileal α-Def 5 via permanent methylation and increase in plasma α-Def 1-3 concentrations offering biomarker utility.

Cerrillo E, Moret I, Iborra M, Ramos D, Busó E, Tortosa L, Sáez-González E, Nos P, Beltrán B.

Clin Exp Immunol. 2018 Apr;192(1):120-128. doi: 10.1111/cei.13085. Epub 2018 Jan 10.

38.

Serial semi-quantitative measurement of fecal calprotectin in patients with ulcerative colitis in remission.

Garcia-Planella E, Mañosa M, Chaparro M, Beltrán B, Barreiro-de-Acosta M, Gordillo J, Ricart E, Bermejo F, García-Sánchez V, Piqueras M, Llaó J, Gisbert JP, Cabré E, Domènech E; PRECUCAL study group Investigators.

Scand J Gastroenterol. 2018 Feb;53(2):152-157. doi: 10.1080/00365521.2017.1410219. Epub 2017 Nov 30.

PMID:
29189092
39.

Primary cutaneous plasmablastic lymphoma in an immunocompetent patient: is it associated with an indolent course?

Beltran BE, Quiñones P, Sanchez G, Paredes A, Moises C, Cotrina E, Torres-Cabala CA, Miranda RN, Castillo JJ.

Leuk Lymphoma. 2018 Jul;59(7):1753-1755. doi: 10.1080/10428194.2017.1393666. Epub 2017 Oct 30. No abstract available.

PMID:
29081245
40.

Serum Adalimumab Levels Predict Successful Remission and Safe Deintensification in Inflammatory Bowel Disease Patients in Clinical Practice.

Aguas Peris M, Bosó V, Navarro B, Marqués-Miñana MR, Bastida G, Beltrán B, Iborra M, Sáez-González E, Monte-Boquet E, Poveda-Andrés JL, Nos P.

Inflamm Bowel Dis. 2017 Aug;23(8):1454-1460. doi: 10.1097/MIB.0000000000001182.

PMID:
28708805
41.

Pretreatment Neutrophil-to-Lymphocyte Ratio and Lymphocyte Recovery: Independent Prognostic Factors for Survival in Pediatric Sarcomas.

Vasquez L, León E, Beltran B, Maza I, Oscanoa M, Geronimo J.

J Pediatr Hematol Oncol. 2017 Oct;39(7):538-546. doi: 10.1097/MPH.0000000000000911.

PMID:
28697168
42.

Response and survival benefit with chemoimmunotherapy in Epstein-Barr virus-positive diffuse large B-cell lymphoma.

Beltran BE, Quiñones P, Morales D, Malaga JM, Chavez JC, Sotomayor EM, Castillo JJ.

Hematol Oncol. 2018 Feb;36(1):93-97. doi: 10.1002/hon.2449. Epub 2017 Jun 22.

PMID:
28639256
43.

Correlation between fecal calprotectin and inflammation in the surgical specimen of Crohn's disease.

Pous-Serrano S, Frasson M, Cerrillo E, Beltrán B, Iborra M, Hervás D, García-Granero E, Nos P.

J Surg Res. 2017 Jun 1;213:290-297. doi: 10.1016/j.jss.2017.02.064. Epub 2017 Mar 6.

PMID:
28601328
44.

Adsorptive granulocyte/monocyte apheresis use in severe ulcerative colitis and determination of changes in plasma cytokines.

Beltrán B, Sáez-González E, Moret I, Díaz-Jaime FC, Alvarez-Sotomayor D, Cerrillo E, Iborra M, Bastida G, Aguas M, Nos P.

J Clin Apher. 2018 Feb;33(1):99-103. doi: 10.1002/jca.21552. Epub 2017 May 9.

PMID:
28485025
45.

Immunological Mechanisms of Adsorptive Cytapheresis in Inflammatory Bowel Disease.

Sáez-González E, Moret I, Alvarez-Sotomayor D, Díaz-Jaime FC, Cerrillo E, Iborra M, Nos P, Beltrán B.

Dig Dis Sci. 2017 Jun;62(6):1417-1425. doi: 10.1007/s10620-017-4577-z. Epub 2017 Apr 21. Review.

PMID:
28432476
46.

Evolution After Anti-TNF Discontinuation in Patients With Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study.

Casanova MJ, Chaparro M, García-Sánchez V, Nantes O, Leo E, Rojas-Feria M, Jauregui-Amezaga A, García-López S, Huguet JM, Arguelles-Arias F, Aicart M, Marín-Jiménez I, Gómez-García M, Muñoz F, Esteve M, Bujanda L, Cortés X, Tosca J, Pineda JR, Mañosa M, Llaó J, Guardiola J, Pérez-Martínez I, Muñoz C, González-Lama Y, Hinojosa J, Vázquez JM, Martinez-Montiel MP, Rodríguez GE, Pajares R, García-Sepulcre MF, Hernández-Martínez A, Pérez-Calle JL, Beltrán B, Busquets D, Ramos L, Bermejo F, Barrio J, Barreiro-de Acosta M, Roncedo O, Calvet X, Hervías D, Gomollón F, Domínguez-Antonaya M, Alcaín G, Sicilia B, Dueñas C, Gutiérrez A, Lorente-Poyatos R, Domínguez M, Khorrami S, Muñoz C, Taxonera C, Rodríguez-Pérez A, Ponferrada A, Van Domselaar M, Arias-Rivera ML, Merino O, Castro E, Marrero JM, Martín-Arranz M, Botella B, Fernández-Salazar L, Monfort D, Opio V, García-Herola A, Menacho M, Ramírez-de la Piscina P, Ceballos D, Almela P, Navarro-Llavat M, Robles-Alonso V, Vega-López AB, Moraleja I, Novella MT, Castaño-Milla C, Sánchez-Torres A, Benítez JM, Rodríguez C, Castro L, Garrido E, Domènech E, García-Planella E, Gisbert JP.

Am J Gastroenterol. 2017 Jan;112(1):120-131. doi: 10.1038/ajg.2016.569. Epub 2016 Dec 13.

PMID:
27958281
47.

Erratum to: Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients.

Iborra M, Gisbert JP, Bosca-Watts MM, López-García A, García-Sánchez V, López-Sanromán A, Hinojosa E, Márquez L, García-López S, Chaparro M, Aceituno M, Calafat M, Guardiola J, Belloc B, Ber Y, Bujanda L, Beltrán B, Rodríguez-Gutiérrez C, Barrio J, Cabriada JL, Rivero M, Camargo R, van Domselaar M, Villoria A, Schuterman HS, Hervás D, Nos P; Spanish Working Group on Crohn’s Disease and Ulcerative Colitis (GETECCU).

J Gastroenterol. 2017 Jul;52(7):875-877. doi: 10.1007/s00535-016-1293-y. No abstract available.

PMID:
27885420
48.

Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naïve and non-naïve patients.

Iborra M, Pérez-Gisbert J, Bosca-Watts MM, López-García A, García-Sánchez V, López-Sanromán A, Hinojosa E, Márquez L, García-López S, Chaparro M, Aceituno M, Calafat M, Guardiola J, Belloc B, Ber Y, Bujanda L, Beltrán B, Rodríguez-Gutiérrez C, Barrio J, Cabriada JL, Rivero M, Camargo R, van Domselaar M, Villoria A, Schuterman HS, Hervás D, Nos P; Spanish Working Group on Crohn’s Disease and Ulcerative Colitis (GETECCU).

J Gastroenterol. 2017 Jul;52(7):788-799. doi: 10.1007/s00535-016-1274-1. Epub 2016 Oct 8. Erratum in: J Gastroenterol. 2017 Jul;52(7):875-877.

PMID:
27722996
49.

Noninvasive Testing for Mucosal Inflammation in Inflammatory Bowel Disease.

Iborra M, Beltrán B, Nos P.

Gastrointest Endosc Clin N Am. 2016 Oct;26(4):641-56. doi: 10.1016/j.giec.2016.06.005. Epub 2016 Aug 9. Review.

PMID:
27633593
50.

Supplemental Content

Loading ...
Support Center